Despite its expensive valuation and declining estimates, we suggest investors hold LLY stock as the company boasts solid ...

Gov. Gavin Newsom will seek to regulate prescription drug intermediaries, eight months after vetoing a similar bill.

Novo Nordisk is doubling down on its oral drug strategy for obesity with a new partnership worth up to $2.2bn with Septerna.

In 2023, the Blue Shield of California announced that it was dropping CVS Caremark as its pharmacy benefit manager (PBM) and ...

Iowa, suggested Congress could once again move to overhaul PBMs’ controversial business practices after legislators pass ...

While M&A activity has slowed in the tail end of the first quarter of 2025, including in healthcare, there have been several noteworthy ...

Sen. Josh Hawley, R-Mo., demanded Tuesday that Congress move to stop insurance companies from owning pharmacy benefit ...

Gov. Gavin Newsom announced today that he will seek to regulate prescription drug middlemen that he blames for driving up ...

Even if the order takes effect, it will do nothing to address the root causes of the problem it purports to solve.

President Donald Trump's new health care initiative aims to reduce prescription drug costs by targeting pharmacy benefit ...

Novo Nordisk inked an obesity deal worth up to $2.2 billion on Wednesday, and sent shares of Septerna into the stratosphere.